FDA Approved Products

4,498 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: LOE ApproachingClear all
SULFAMETHOXAZOLE AND TRIMETHOPRIM
sulfamethoxazole; trimethoprim
LOE Approaching
TevaTeva
ORAL · SUSPENSION
1983
NDA
30/100
SULFAMETHOXAZOLE AND TRIMETHOPRIM
sulfamethoxazole; trimethoprim
LOE Approaching
TevaTeva
ORAL · TABLET
1983
NDA
30/100
SULFAMETHOXAZOLE AND TRIMETHOPRIM
sulfamethoxazole; trimethoprim
LOE Approaching
FP
Fosun Pharma
ORAL · TABLET
1982
NDA
30/100
SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE
phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim
LOE Approaching
ORAL · TABLET
2001
NDA
30/100
SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
sulfamethoxazole; trimethoprim
LOE Approaching
FP
Fosun Pharma
ORAL · TABLET
1982
NDA
30/100
SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
sulfamethoxazole; trimethoprim
LOE Approaching
TevaTeva
ORAL · TABLET
1983
NDA
30/100
SULFAMYLON
mafenide acetate
LOE Approaching
TOPICAL · CREAM
1969
NDA
30/100
SULFAMYLON
mafenide acetate
LOE Approaching
Viatris (2)Viatris (2)
TOPICAL · FOR SOLUTION
1998
NDA
30/100
SULFAPYRIDINE
sulfapyridine
LOE Approaching
Eli Lilly and CompanyEli Lilly and Company
ORAL · TABLET
1939
NDA
30/100
SULFATRIM
sulfamethoxazole and trimethoprim
LOE Approaching
InpharmusInpharmus
ORAL · SUSPENSION
1983
NDA
30/100
SULFATRIM PEDIATRIC
sulfamethoxazole and trimethoprim
LOE Approaching
InpharmusInpharmus
ORAL · SUSPENSION
1983
NDA
30/100
SULLA
sulfameter
LOE Approaching
BayerBayer
ORAL · TABLET
1966
NDA
30/100
SULTRIN
triple sulfa (sulfabenzamide; sulfacetamide; sulfathiazole)
LOE Approaching
J&
Johnson & Johnson
VAGINAL · CREAM
1945
NDA
30/100
SUPPRELIN
histrelin acetate
LOE Approaching
TakedaTakeda
INJECTION · INJECTABLE
1991
NDA
30/100
SUPRANE
desflurane
LOE Approaching
B
Baxter
INHALATION · LIQUID
1992
NDA
30/100
SUPRAX
cefixime
LOE Approaching
PfizerPfizer
ORAL · FOR SUSPENSION
1989
NDA
30/100
SUPRAX
cefixime
LOE Approaching
PfizerPfizer
ORAL · TABLET
1989
NDA
30/100
SURITAL
thiamylal sodium
LOE Approaching
PfizerPfizer
INJECTION · INJECTABLE
1954
NDA
30/100
SURMONTIL
trimipramine maleate
LOE Approaching
TevaTeva
ORAL · CAPSULE
1979
NDA
30/100
SUS-PHRINE SULFITE FREE
epinephrine
LOE Approaching
Forest DevicesForest Devices
INJECTION · INJECTABLE
1951
NDA
30/100
SUSTIVA
efavirenz
LOE Approaching
Bristol Myers SquibbBristol Myers Squibb
ORAL · CAPSULE
1998
NDA
30/100
SUSTIVA
efavirenz
LOE Approaching
Bristol Myers SquibbBristol Myers Squibb
ORAL · TABLET
2002
NDA
30/100
SUTENT
sunitinib malate
LOE Approaching
ORAL · CAPSULE
2006
NDA
30/100
SUTENT
sunitinib malate
LOE Approaching
ORAL · CAPSULE
2006
NDA
30/100
← PreviousPage 150 of 188Next →